Research output per year
Research output per year
Fingerprint
The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.
- 1 Similar Profiles
Collaborations from the last five years
Dive into details by clicking on the dots.
-
Frequency and Functional Characterization of RUNX1 Germline Variants in Myeloid Neoplasms
Nitschke, N. J., Almosailleakh, M., Niu, Y., Hansen, J. W., Raaschou-Jensen, K., Jespersen, J. S., Severinsen, M. T., Roug, A. S., Frödin, M., Weischenfeldt, J. L., Andersen, M. K. & Grønbæk, K., 2 Jun 2023, In: Human Mutation. 2023, 11 p., 4738660 .Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile21 Downloads (Pure) -
Use of statins and risk of myeloproliferative neoplasms - a Danish nationwide case-control study
Kristensen, D. T., Øvlisen, A. K., Jakobsen, L. H. K., Severinsen, M. T., Hannig, L. H., Starklint, J., Hilsøe, M. H., Vallentin, A. P., Brabrand, M., Hasselbalch, H. C., El-Galaly, T. C. & Roug, A. S., 25 Jul 2023, In: Blood advances. 7, 14, p. 3450-3457 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile4 Downloads (Pure) -
Venetoclax-based therapy for relapsed or refractory acute myeloid leukaemia following intensive induction chemotherapy
Kristensen, D. T., Brøndum, R. F., Ørskov, A. D., Marcher, C. W., Schöllkopf, C., Sørensen, A. L. T., Severinsen, M. T., Bøgsted, M. & Roug, A. S., Oct 2023, In: European Journal of Haematology. 111, 4, p. 573-582 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open Access -
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation
Soerensen, J. F., Aggerholm, A., Rosenberg, C. A., Bill, M., Kerndrup, G. B., Ebbesen, L. H., Hansen, M. H., Roug, A. S. & Ludvigsen, M., Mar 2022, In: Bone Marrow Transplantation. 57, 3, p. 460-465 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
4 Citations (Scopus) -
Effects of Chemotherapy Dose Reductions in Overweight and Obese Patients with Acute Myeloid Leukemia – A Danish Nationwide Cohort Study
Kristensen, D., Nielsen, L. B., Jakobsen, L. H., Kristensen, T-C. C., El-Galaly, T. C., Roug, A. S. & Severinsen, M. T., 23 Jul 2022, In: HemaSphere. 6, Suppl. 3, p. 858-859 2 p., P546.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open AccessFile13 Downloads (Pure)
Datasets
-
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
Schmitz, A. (Creator), Brøndum, R. F. (Creator), Johnsen, H. E. (Creator), Mellqvist, U. (Creator), Waage, A. (Creator), Gimsing, P. (Creator), op Bruinink, D. H. (Creator), van der Velden, V. (Creator), van der Holt, B. (Creator), Hansson, M. (Creator), Andersen, N. F. (Creator), Frølund, U. C. (Creator), Helleberg, C. (Creator), Schjesvold, F. H. (Creator), Ahlberg, L. (Creator), Gulbrandsen, N. (Creator), Andreasson, B. (Creator), Lauri, B. (Creator), Haukas, E. (Creator), Bødker, J. S. (Creator), Roug, A. S. (Creator), Bøgsted, M. (Creator), Severinsen, M. T. (Creator), Gregersen, H. E. (Creator), Abildgaard, N. (Creator), Sonneveld, P. (Creator) & Dybkær, K. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.c.5827973.v1, https://springernature.figshare.com/collections/Longitudinal_minimal_residual_disease_assessment_in_multiple_myeloma_patients_in_complete_remission_results_from_the_NMSG_flow-MRD_substudy_within_the_EMN02_HO95_MM_trial/5827973/1
Dataset
-
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
Schmitz, A. (Creator), Brøndum, R. F. (Creator), Johnsen, H. E. (Creator), Mellqvist, U. (Creator), Waage, A. (Creator), Gimsing, P. (Creator), op Bruinink, D. H. (Creator), van der Velden, V. (Creator), van der Holt, B. (Creator), Hansson, M. (Creator), Andersen, N. F. (Creator), Frølund, U. C. (Creator), Helleberg, C. (Creator), Schjesvold, F. H. (Creator), Ahlberg, L. (Creator), Gulbrandsen, N. (Creator), Andreasson, B. (Creator), Lauri, B. (Creator), Haukas, E. (Creator), Bødker, J. S. (Creator), Roug, A. S. (Creator), Bøgsted, M. (Creator), Severinsen, M. T. (Creator), Gregersen, H. E. (Creator), Abildgaard, N. (Creator), Sonneveld, P. (Creator) & Dybkær, K. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.c.5827973, https://springernature.figshare.com/collections/Longitudinal_minimal_residual_disease_assessment_in_multiple_myeloma_patients_in_complete_remission_results_from_the_NMSG_flow-MRD_substudy_within_the_EMN02_HO95_MM_trial/5827973
Dataset
-
Additional file 1 of Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
Schmitz, A. (Creator), Brøndum, R. F. (Creator), Johnsen, H. E. (Creator), Mellqvist, U. (Creator), Waage, A. (Creator), Gimsing, P. (Creator), op Bruinink, D. H. (Creator), van der Velden, V. (Creator), van der Holt, B. (Creator), Hansson, M. (Creator), Andersen, N. F. (Creator), Frølund, U. C. (Creator), Helleberg, C. (Creator), Schjesvold, F. H. (Creator), Ahlberg, L. (Creator), Gulbrandsen, N. (Creator), Andreasson, B. (Creator), Lauri, B. (Creator), Haukas, E. (Creator), Bødker, J. S. (Creator), Roug, A. S. (Creator), Bøgsted, M. (Creator), Severinsen, M. T. (Creator), Gregersen, H. E. (Creator), Abildgaard, N. (Creator), Sonneveld, P. (Creator) & Dybkær, K. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.19128644.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Longitudinal_minimal_residual_disease_assessment_in_multiple_myeloma_patients_in_complete_remission_results_from_the_NMSG_flow-MRD_substudy_within_the_EMN02_HO95_MM_trial/19128644/1
Dataset
-
Supplementary Table_S1: Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system.xlsx
Brøndum, R. F. (Creator), Vestergaard, A. S. (Creator), Børty, L. (Creator), Vesteghem, C. P. E. (Creator), Rytter, A. S. (Creator), Nielsen, M. M. (Creator), Severinsen, M. T. (Creator), Jensen, P. (Creator), Gregersen, H. E. (Creator), El-Galaly, T. (Creator), Dybkær, K. (Creator), Ehlers, L. H. (Creator), Bøgsted, M. (Creator) & Roug, A. S. (Creator), Future Science Group, 22 Jun 2021
DOI: 10.25402/fon.14823033.v1, https://future-science-group.figshare.com/articles/dataset/Supplementary_Table_S1_Direct_costs_of_antineoplastic_and_supportive_treatment_for_progressive_multiple_myeloma_in_a_tax-based_health_system_xlsx/14823033/1
Dataset: Supplementary material
-
Supplementary Table_S1: Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system.xlsx
Brøndum, R. F. (Creator), Vestergaard, A. S. (Creator), Børty, L. (Creator), Vesteghem, C. P. E. (Creator), Rytter, A. S. (Creator), Nielsen, M. M. (Creator), Severinsen, M. T. (Creator), Jensen, P. (Creator), Gregersen, H. E. (Creator), El-Galaly, T. (Creator), Dybkær, K. (Creator), Ehlers, L. H. (Creator), Bøgsted, M. (Creator) & Roug, A. S. (Creator), Future Science Group, 2021
DOI: 10.25402/fon.14823033, https://future-science-group.figshare.com/articles/dataset/Supplementary_Table_S1_Direct_costs_of_antineoplastic_and_supportive_treatment_for_progressive_multiple_myeloma_in_a_tax-based_health_system_xlsx/14823033
Dataset